Algeria vs Myanmar: Hypertension: effective treatment coverage (controlled hypertension)
Algeria
15.3%
in 2019
Myanmar
14.9%
in 2019
Algeria rank
108th
Myanmar rank
110th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Algeria
- Myanmar
How they compare
Algeria currently reports 15.3% against 14.9% in Myanmar, a difference of 0.4%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Myanmar ahead.
Algeria ranks 108th and Myanmar ranks 110th of 193 countries.
Across the 3 decades both report, Algeria averaged higher in 1 and Myanmar in 2.
Head to head by decade
| Decade | Algeria | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.7% | 4.4% | 0.6% | Myanmar |
| 2000s | 7.0% | 8.0% | 1.0% | Myanmar |
| 2010s | 13.4% | 13.0% | 0.4% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Algeria or Myanmar?
- Algeria, at 15.3% against 14.9% in Myanmar as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Algeria and Myanmar?
- 0.4%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Myanmar?
- 30 years are reported by both, from 1990 to 2019.
- How do Algeria and Myanmar rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Algeria ranks 108th and Myanmar ranks 110th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.